{
    "nctId": "NCT02339779",
    "briefTitle": "Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy",
    "officialTitle": "the Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy Trial",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 196,
    "primaryOutcomeMeasure": "Breast-related Quality of life (BREAST_Q)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female gender\n* Age of 18 years and older\n* History or in candidate for a mastectomy procedure in the near future\n* Patients' choice to undergo a breast reconstruction\n* Wanting to participate in this study\n* Patient is able to wear the BRAVA device\n\nExclusion Criteria:\n\n* Active smoker or a history of smoking 4 weeks prior to surgery\n* Current substance abuse\n* History of lidocaine allergy\n* History of silicone allergy\n* 4 weeks or less after chemotherapy\n* History of radiation therapy in the breast region\n* Oncological treatment includes radiotherapy after mastectomy\n* Kidney disease\n* Steroid dependent asthma (daily or weekly) or other diseases\n* Immune-suppressed or compromised disease\n* Uncontrolled diabetes\n* BMI\\>30\n* Large breast size (i.e. larger than cup C), unless the patient prefers reduction of the contralateral side towards Cup C\n* Extra-capsular silicone leaking from the encapsulated implant from a previous breast reconstruction\n* The treating plastic surgeon has strong doubts on the patient's treatment compliance\n* Claustrophobia for an MRI-scan",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}